ClinicalTrials.gg
CompletedNCT01032928RSPTUpdated Jan 1, 2015Results posted

Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer

A Phase 2 interventional study of Respiratory-Swallow Phase training in Oropharyngeal Dysphagia and Oropharyngeal Cancer, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2015-01-01.

Sponsored by US Department of Veterans Affairs · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

Cancers of the head and neck require surgical, radiation, and chemotherapy treatments that are intended to cure the disease. These treatments have toxic effects on muscles and structures that are necessary to swallow safely and efficiently. The resulting swallowing problems (dysphagia) often remain chronic for Veterans and interfere with their ability to eat and drink. The cost burden to the VA health system is high. There is an urgent need to develop rehabilitative treatments that lessen these burdens. The proposed research is designed to test a novel swallowing therapy that includes the coordination of breathing with swallowing. Our study will train medically and surgically treated, chronically dysphagic Veterans with histories of oropharyngeal cancer in a novel therapy that involves both swallowing and respiratory systems. If the therapy is found to be effective, the long term goal of the project is to extend the study to a multi-site, clinical trial and test the longstanding effect of this treatment compared to other swallowing therapies on swallowing function, QOL and cost.

Read the detailed description

Swallowing impairments (dysphagia) represent the highest functional morbidity in veteran patients treated for oropharyngeal cancers with either surgical approaches followed by radiation or with more recent organ-preservation protocols. The nature of the impairments is often resistive to treatment and results in life-long health consequences and high cost burden on the VA health system. Recent preliminary data have linked alterations in the otherwise highly stable respiratory-swallowing phase pattern relationships to the swallowing impairment and penetration/aspiration and in this patient group. The immediate goal of this clinical trial is to test the effect of a novel respiratory-swallow intervention on swallowing impairment and penetration/aspiration in a cohort of chronically dysphagic veterans following treatment for oropharyngeal cancer. Patients presenting with a "non-optimal" respiratory-swallow phase pattern during liquid swallows and measurable swallowing impairment will learn an "optimal" physiologic pattern that facilitates both airway protective and mechanical advantages during swallowing. The broad goal of this research is to develop ideal respiratory-swallowing phase training methods and regimens that alone or combined with traditional swallowing treatments improve swallowing function in the acute phases of recovery and improve long term patient outcome. Our intention is to use these preliminary data to motivate a larger clinical trial to compare the effect of respiratory-swallow phase training with other evidenced based methods of swallowing treatment and expand the approach to other patient groups that have indications of respiratory-swallow phase impairments (e.g. pulmonary disease and stroke) contributing to impaired swallowing function

02

Conditions studied

  • Oropharyngeal Dysphagia
  • Oropharyngeal Cancer

Keywords

  • Swallowing
  • Dysphagia
  • Breathing and swallowing
  • Oropharyngeal cancer
03

In context

Deglutition Disorders

723 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 482 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 675 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least 21 years of age
  • agreed to participate in this study and signed an informed consent, either completed by the participant or designated other
  • have chronic impairments in oropharyngeal swallowing function following chemotherapy, radiation, and/or surgical intervention for the treatment of first time diagnosis of squamous cell carcinoma of the head and neck
  • have completed medical treatments for his/her cancer and any traditional swallowing therapy at least 6 months earlier
  • pass a cognitive screening (COGNISTAT)
  • have at least one area of impairment (initiation of pharyngeal swallow, anterior hyolaryngeal excursion, extent and duration of PES opening, tongue base retraction, pharyngeal residue) as indicated by the results of the pre-intervention MBSImP (total sum MBSImP
  • have PAS scores >/= 3 on 10% of swallows on pre-intervention MBSS
  • have a non-optimal (E-I, I-E, or I-I) breathing pattern on 60% of trial swallows.

Exclusion criteria

Exclusion Criteria:

  • known allergy or dietary restriction for food or contrast materials used during the exam
  • evidence of persistent or recurrent disease on physical examination of the head and neck
  • evidence of esophageal stricture noted on MBS
  • recurrent oropharyngeal cancer and/or are being treated for other cancer(s) concurrently
  • severe COPD (see Pulmonary Criteria below)
  • nasogastric feeding tube
  • recent change in swallowing status characterized by increase in perceived or observed -swallowing problems by patient, family or testing SLP
  • any co-occurring neurological impairment affecting muscle strength and/or cognition
  • history of aspiration pneumonia over the past 12 months.
  • fail cognitive screening
  • absence of swallowing impairment
  • evidence of esophageal stricture on MBS
  • inability to tolerate at least one of the liquid barium consistencies
  • consistent optimal respiratory-swallow phase patterning
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Respiratory Phase Training

    Chronically dysphagic, medically stable patients at least 6 months post treatment for head and neck cancer with non-optimal respiratory-swallowing patterns participated in up to 8 sessions of respiratory phase training to learn an optimal respiratory - swallow phase pattern

    Behavioral: Respiratory-Swallow Phase training

Interventions

  • BehavioralRespiratory-Swallow Phase training

    Patients were presented with visually guided respiratory feedback to train optimal respiratory-swallow coordination patterns.

06

What researchers measure

Primary outcomes

  1. Optimal Respiratory - Swallow Phase

    Respiratory swallow patterns were collected using nasal airflow and respiratory inductance plethysmography (RIP) of each swallow during the modified barium swallow study. The movements of the ribcage and abdomen were recorded using RIP; data synchronized and recorded using the KayPentax Digital Swallow Workstation Signals Lab. Subjects were categorized as optimal (expiratory-expiratory) versus non-optimal (non-expiratory-expiratory).

    Time frame: Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks

Secondary outcomes

  1. Percentage of Impairment According to the Modified Barium Swallow Impairment Profile (MBSImP)

    Analysis of the percentage of impaired swallow components using a dichotomized MBSImP scoring system

    Time frame: Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks

  2. Percentage of Impairment According to the Penetration-Aspiration Scale

    The penetration aspiration scale is a validated 8 point interval scale used to describe penetration and aspiration events. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled. Scores \< 3 are considered to be normal. For the purpose of our study scores were dichotimized to normal and impaired.

    Time frame: Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks

07

Results

Posted Dec 4, 2014

Participant flow

Participants were recruited from the Head and Neck Clinics at the Ralph H Johnson Veterans Administration Medical Center and the Medical University of South Carolina between May 2010 and April 2013

Participant flow — Overall Study
MilestoneRespiratory - Swallow Phase Training
Started30
Completed30
Not completed0

Outcome measures

SecondaryPercentage of Impairment According to the Modified Barium Swallow Impairment Profile (MBSImP)

Analysis of the percentage of impaired swallow components using a dichotomized MBSImP scoring system

Time frame:
Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks
Reported as:
Number · percentage of impairment
Percentage of Impairment According to the Modified Barium Swallow Impairment Profile (MBSImP)
percentage of impairmentPre-interventionOne Week Post InterventionOne Month Post Intervention
Lip closure5.79.32.8
Tongue control58.753.859.2
Bolus transport37.350.241.5
Oral residue77.376.471.1
Initiation of pharyngeal swallow90.490.891.1
Soft palate elevation19.831.015.6
laryngeal elevation76.670.863.3
Anterior hyiod excursion94.790.593.3
Epiglottic inversion71.968.355.6
Laryngeal vestibular closure78.255.562.2
Pharyngeal stripping wave59.367.660.7
Pharyngoesophageal segment opening80.680.570.0
Tongue base retraction96.088.680.7
Pharyngeal residue96.188.483.0
SecondaryPercentage of Impairment According to the Penetration-Aspiration Scale

The penetration aspiration scale is a validated 8 point interval scale used to describe penetration and aspiration events. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled. Scores \< 3 are considered to be normal. For the purpose of our study scores were dichotimized to normal and impaired.

Time frame:
Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks
Reported as:
Number · percentage of swallows with impaired PAS
Percentage of Impairment According to the Penetration-Aspiration Scale
percentage of swallows with impaired PASPre-interventionOne Week Post InterventionOne Month Post Intervention
Percentage of Impairment According to the Penetration-Aspiration Scale78.038.342.2
PrimaryOptimal Respiratory - Swallow Phase

Respiratory swallow patterns were collected using nasal airflow and respiratory inductance plethysmography (RIP) of each swallow during the modified barium swallow study. The movements of the ribcage and abdomen were recorded using RIP; data synchronized and recorded using the KayPentax Digital Swallow Workstation Signals Lab. Subjects were categorized as optimal (expiratory-expiratory) versus non-optimal (non-expiratory-expiratory).

Time frame:
Patient were assessed pre-treatment, one week post treatment and one month post treatment. Treatment sessions were twice weekly for up to 4 weeks
Reported as:
Number · percentage of swallows
Optimal Respiratory - Swallow Phase
percentage of swallowsPre-interventionOne Week Post-interventionOne Month Post Intervention
Optimal Respiratory - Swallow Phase438688.1

Adverse events

Collected over Duration of the study. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Arm 1—0/30 (0%)0/30 (0%)

Baseline characteristics

Entire Enrolled Study Population

Age, Categorical
Age, Categorical(Participants)Respiratory-Swallow Phase Training
<=18 years0
Between 18 and 65 years17
>=65 years13
Age, Continuous
Age, Continuous(years)Respiratory-Swallow Phase Training
Mean61 ± 11
Sex: Female, Male
Sex: Female, Male(Participants)Respiratory-Swallow Phase Training
Female4
Male26
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Respiratory-Swallow Phase Training
Hispanic or Latino0
Not Hispanic or Latino30
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Respiratory-Swallow Phase Training
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American4
White26
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Respiratory-Swallow Phase Training
United States30
08

Study locations

1 site
  • Ralph H Johnson VA Medical Center, Charleston
    Charleston, South Carolina 29401-5799, United States
09

References and documents

Publications

  • Martin-Harris B, McFarland D, Hill EG, Strange CB, Focht KL, Wan Z, Blair J, McGrattan K. Respiratory-swallow training in patients with head and neck cancer. Arch Phys Med Rehabil. 2015 May;96(5):885-93. doi: 10.1016/j.apmr.2014.11.022. Epub 2014 Dec 11. PubMed 25498307 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01032928
Responsible party
Sponsor
First posted
Dec 16, 2009
Start date
Jun 2011
Primary completion
Jul 2013
Completion
Sep 2013
Results posted
Dec 4, 2014
Last update
Jan 1, 2015

Study contacts

Bonnie J Martin-Harris
principal investigator · Ralph H Johnson VA Medical Center, Charleston

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion